Cargando…

Epicardial adipose tissue volume and CT-attenuation as prognostic factors for pulmonary embolism and mortality in critically ill patients affected by COVID-19

BACKGROUND/OBJECTIVES: The aim of this post-hoc analysis was to evaluate if epicardial adipose tissue (EAT) quantity and quality, as evaluated by computed tomography (CT), have a different role in the risk of mortality and pulmonary embolism in critically ill COVID-19 patients admitted to an intensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Andrea P., Donadello, Katia, Schweiger, Vittorio, Zamboni, Giulia A., Dalla Valle, Zeno, Zamboni, Mauro, Polati, Enrico, Gottin, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412799/
https://www.ncbi.nlm.nih.gov/pubmed/36028776
http://dx.doi.org/10.1038/s41430-022-01197-0
_version_ 1784775583091130368
author Rossi, Andrea P.
Donadello, Katia
Schweiger, Vittorio
Zamboni, Giulia A.
Dalla Valle, Zeno
Zamboni, Mauro
Polati, Enrico
Gottin, Leonardo
author_facet Rossi, Andrea P.
Donadello, Katia
Schweiger, Vittorio
Zamboni, Giulia A.
Dalla Valle, Zeno
Zamboni, Mauro
Polati, Enrico
Gottin, Leonardo
author_sort Rossi, Andrea P.
collection PubMed
description BACKGROUND/OBJECTIVES: The aim of this post-hoc analysis was to evaluate if epicardial adipose tissue (EAT) quantity and quality, as evaluated by computed tomography (CT), have a different role in the risk of mortality and pulmonary embolism in critically ill COVID-19 patients admitted to an intensive care unit (ICU). SUBJECTS/METHODS: CT derived EAT volume and density, as well as anthropometric and blood biomarkers, were evaluated in a sample of 138 subjects, 109 men and 29 women, for whom CT images and information on pulmonary embolism were available from a total of 313 subjects who were consecutively admitted to the ICU for COVID-19 from the REINSURE-ARDS prospective registry. RESULTS: A total of 28 patients (20.3%) died during the first 28 days after ICU admission. 26 subjects out of 138 had pulmonary embolism (18.8%). Age, weight, BMI, IL-6 levels and pulmonary embolism prevalence were significantly higher across EAT volume tertiles. Subjects who died in the first 28 days from ICU admission were older, had higher EAT volume, D-dimer, LDH and IL-6 level. After adjustment for age and gender, participants in tertile 3 of EAT volume had lower survival at 28 days from ICU admission as compared to subjects in the tertile 1, HR 2.95 (95% C.I. 1.02–8.49), but after adjusting for potential confounders the relation was no longer significant. No relation between EAT density and mortality was observed. From a binary logistic regression, subjects in tertile 3 of EAT volume and in tertile 1 of EAT density showed a 4 times and 3.6 times increased risk of pulmonary embolism, respectively. CONCLUSIONS: ICU subjects affected by severe COVID-19 with higher EAT volume and low EAT density should be carefully monitored and managed with a prompt and aggressive approach, to prevent serious and life-threatening consequences and the increase of hospital treatment costs.
format Online
Article
Text
id pubmed-9412799
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94127992022-08-26 Epicardial adipose tissue volume and CT-attenuation as prognostic factors for pulmonary embolism and mortality in critically ill patients affected by COVID-19 Rossi, Andrea P. Donadello, Katia Schweiger, Vittorio Zamboni, Giulia A. Dalla Valle, Zeno Zamboni, Mauro Polati, Enrico Gottin, Leonardo Eur J Clin Nutr Article BACKGROUND/OBJECTIVES: The aim of this post-hoc analysis was to evaluate if epicardial adipose tissue (EAT) quantity and quality, as evaluated by computed tomography (CT), have a different role in the risk of mortality and pulmonary embolism in critically ill COVID-19 patients admitted to an intensive care unit (ICU). SUBJECTS/METHODS: CT derived EAT volume and density, as well as anthropometric and blood biomarkers, were evaluated in a sample of 138 subjects, 109 men and 29 women, for whom CT images and information on pulmonary embolism were available from a total of 313 subjects who were consecutively admitted to the ICU for COVID-19 from the REINSURE-ARDS prospective registry. RESULTS: A total of 28 patients (20.3%) died during the first 28 days after ICU admission. 26 subjects out of 138 had pulmonary embolism (18.8%). Age, weight, BMI, IL-6 levels and pulmonary embolism prevalence were significantly higher across EAT volume tertiles. Subjects who died in the first 28 days from ICU admission were older, had higher EAT volume, D-dimer, LDH and IL-6 level. After adjustment for age and gender, participants in tertile 3 of EAT volume had lower survival at 28 days from ICU admission as compared to subjects in the tertile 1, HR 2.95 (95% C.I. 1.02–8.49), but after adjusting for potential confounders the relation was no longer significant. No relation between EAT density and mortality was observed. From a binary logistic regression, subjects in tertile 3 of EAT volume and in tertile 1 of EAT density showed a 4 times and 3.6 times increased risk of pulmonary embolism, respectively. CONCLUSIONS: ICU subjects affected by severe COVID-19 with higher EAT volume and low EAT density should be carefully monitored and managed with a prompt and aggressive approach, to prevent serious and life-threatening consequences and the increase of hospital treatment costs. Nature Publishing Group UK 2022-08-26 2023 /pmc/articles/PMC9412799/ /pubmed/36028776 http://dx.doi.org/10.1038/s41430-022-01197-0 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2022, corrected publication 2022Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Rossi, Andrea P.
Donadello, Katia
Schweiger, Vittorio
Zamboni, Giulia A.
Dalla Valle, Zeno
Zamboni, Mauro
Polati, Enrico
Gottin, Leonardo
Epicardial adipose tissue volume and CT-attenuation as prognostic factors for pulmonary embolism and mortality in critically ill patients affected by COVID-19
title Epicardial adipose tissue volume and CT-attenuation as prognostic factors for pulmonary embolism and mortality in critically ill patients affected by COVID-19
title_full Epicardial adipose tissue volume and CT-attenuation as prognostic factors for pulmonary embolism and mortality in critically ill patients affected by COVID-19
title_fullStr Epicardial adipose tissue volume and CT-attenuation as prognostic factors for pulmonary embolism and mortality in critically ill patients affected by COVID-19
title_full_unstemmed Epicardial adipose tissue volume and CT-attenuation as prognostic factors for pulmonary embolism and mortality in critically ill patients affected by COVID-19
title_short Epicardial adipose tissue volume and CT-attenuation as prognostic factors for pulmonary embolism and mortality in critically ill patients affected by COVID-19
title_sort epicardial adipose tissue volume and ct-attenuation as prognostic factors for pulmonary embolism and mortality in critically ill patients affected by covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412799/
https://www.ncbi.nlm.nih.gov/pubmed/36028776
http://dx.doi.org/10.1038/s41430-022-01197-0
work_keys_str_mv AT rossiandreap epicardialadiposetissuevolumeandctattenuationasprognosticfactorsforpulmonaryembolismandmortalityincriticallyillpatientsaffectedbycovid19
AT donadellokatia epicardialadiposetissuevolumeandctattenuationasprognosticfactorsforpulmonaryembolismandmortalityincriticallyillpatientsaffectedbycovid19
AT schweigervittorio epicardialadiposetissuevolumeandctattenuationasprognosticfactorsforpulmonaryembolismandmortalityincriticallyillpatientsaffectedbycovid19
AT zambonigiuliaa epicardialadiposetissuevolumeandctattenuationasprognosticfactorsforpulmonaryembolismandmortalityincriticallyillpatientsaffectedbycovid19
AT dallavallezeno epicardialadiposetissuevolumeandctattenuationasprognosticfactorsforpulmonaryembolismandmortalityincriticallyillpatientsaffectedbycovid19
AT zambonimauro epicardialadiposetissuevolumeandctattenuationasprognosticfactorsforpulmonaryembolismandmortalityincriticallyillpatientsaffectedbycovid19
AT polatienrico epicardialadiposetissuevolumeandctattenuationasprognosticfactorsforpulmonaryembolismandmortalityincriticallyillpatientsaffectedbycovid19
AT gottinleonardo epicardialadiposetissuevolumeandctattenuationasprognosticfactorsforpulmonaryembolismandmortalityincriticallyillpatientsaffectedbycovid19